IBDEI090 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3668,2)
 ;;=^5015372
 ;;^UTILITY(U,$J,358.3,3669,0)
 ;;=M54.9^^28^258^28
 ;;^UTILITY(U,$J,358.3,3669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3669,1,3,0)
 ;;=3^Dorsalgia,Unspec
 ;;^UTILITY(U,$J,358.3,3669,1,4,0)
 ;;=4^M54.9
 ;;^UTILITY(U,$J,358.3,3669,2)
 ;;=^5012314
 ;;^UTILITY(U,$J,358.3,3670,0)
 ;;=M53.9^^28^258^29
 ;;^UTILITY(U,$J,358.3,3670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3670,1,3,0)
 ;;=3^Dorsopathy,Unspec
 ;;^UTILITY(U,$J,358.3,3670,1,4,0)
 ;;=4^M53.9
 ;;^UTILITY(U,$J,358.3,3670,2)
 ;;=^5012284
 ;;^UTILITY(U,$J,358.3,3671,0)
 ;;=M43.9^^28^258^25
 ;;^UTILITY(U,$J,358.3,3671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3671,1,3,0)
 ;;=3^Deforming Dorsopathy,Unspec
 ;;^UTILITY(U,$J,358.3,3671,1,4,0)
 ;;=4^M43.9
 ;;^UTILITY(U,$J,358.3,3671,2)
 ;;=^5011959
 ;;^UTILITY(U,$J,358.3,3672,0)
 ;;=R60.1^^28^258^30
 ;;^UTILITY(U,$J,358.3,3672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3672,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,3672,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,3672,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,3673,0)
 ;;=R60.0^^28^258^31
 ;;^UTILITY(U,$J,358.3,3673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3673,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,3673,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,3673,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,3674,0)
 ;;=R60.9^^28^258^32
 ;;^UTILITY(U,$J,358.3,3674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3674,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,3674,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,3674,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,3675,0)
 ;;=M72.9^^28^258^33
 ;;^UTILITY(U,$J,358.3,3675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3675,1,3,0)
 ;;=3^Fibroblastic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3675,1,4,0)
 ;;=4^M72.9
 ;;^UTILITY(U,$J,358.3,3675,2)
 ;;=^5013237
 ;;^UTILITY(U,$J,358.3,3676,0)
 ;;=M79.7^^28^258^34
 ;;^UTILITY(U,$J,358.3,3676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3676,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,3676,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,3676,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,3677,0)
 ;;=M84.50XA^^28^258^36
 ;;^UTILITY(U,$J,358.3,3677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3677,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,3677,1,4,0)
 ;;=4^M84.50XA
 ;;^UTILITY(U,$J,358.3,3677,2)
 ;;=^5014022
 ;;^UTILITY(U,$J,358.3,3678,0)
 ;;=M84.50XD^^28^258^39
 ;;^UTILITY(U,$J,358.3,3678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3678,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Routine Healing
 ;;^UTILITY(U,$J,358.3,3678,1,4,0)
 ;;=4^M84.50XD
 ;;^UTILITY(U,$J,358.3,3678,2)
 ;;=^5014023
 ;;^UTILITY(U,$J,358.3,3679,0)
 ;;=M84.50XS^^28^258^40
 ;;^UTILITY(U,$J,358.3,3679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3679,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Sequela
 ;;^UTILITY(U,$J,358.3,3679,1,4,0)
 ;;=4^M84.50XS
 ;;^UTILITY(U,$J,358.3,3679,2)
 ;;=^5014027
 ;;^UTILITY(U,$J,358.3,3680,0)
 ;;=M84.50XG^^28^258^35
 ;;^UTILITY(U,$J,358.3,3680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3680,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Delayed Healing
 ;;^UTILITY(U,$J,358.3,3680,1,4,0)
 ;;=4^M84.50XG
 ;;^UTILITY(U,$J,358.3,3680,2)
 ;;=^5014024
 ;;^UTILITY(U,$J,358.3,3681,0)
 ;;=M84.50XK^^28^258^38
 ;;^UTILITY(U,$J,358.3,3681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3681,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Nonunion
 ;;^UTILITY(U,$J,358.3,3681,1,4,0)
 ;;=4^M84.50XK
 ;;^UTILITY(U,$J,358.3,3681,2)
 ;;=^5014025
 ;;^UTILITY(U,$J,358.3,3682,0)
 ;;=M84.50XP^^28^258^37
